NCT05174741 Pulmonary Rehabilitation in Non-chronic Obstructive Pulmonary Disease Patients. Status UNKNOWN Phase NA
NCT05121779 Head-to-head Comparison of Diagnosis Value of Pulmonary Fibrosis on 68Ga-FAPI-04 and 18F-FDG PET-CT Status RECRUITING Phase PHASE1
NCT04987606 Post COVID-19 Interstitial Lung Disease: A Study of Genetic and Environmental Interactions Status COMPLETED Phase N/A
NCT04987528 Pulmonary Fibrosis During Severe COVID-19 Pneumonia Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04979884 Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital Status COMPLETED Phase PHASE3
NCT04948203 Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT04930289 Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs Status ENROLLING_BY_INVITATION Phase N/A
NCT04805086 The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19 Status UNKNOWN Phase PHASE1/PHASE2
NCT04680832 Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04638517 The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Improve Health Outcomes for Adults and Children With Pulmonary Fibrosis Status TERMINATED Phase PHASE2
NCT04619680 The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19 Status COMPLETED Phase PHASE4
NCT04537130 Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge Status UNKNOWN Phase PHASE1
NCT04517162 Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients Status UNKNOWN Phase PHASE1/PHASE2
NCT04488562 Home Monitoring and Evaluation After Admission for COVID-19 in the Netherlands Status COMPLETED Phase N/A
NCT04482595 BIO 300 Oral Suspension in Previously Hospitalized Long COVID Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2